Veterinary | Cyclosporin drops, ophthalmic 1%, solution, Rx only, compounded by Moses Lake Pharmacy. | t09242014@14; t10062014@3; t10062014@29; t02032015@22; t06252015@29; | Class II | The firm is recalling Cyclosporin drops, ophthalmic 1% due to lack of sterility assurance | JD & SN Inc., dba Moses Lake Professional Pharmacy |
Veterinary | Buprenorphine, multidose sterile vial, 03.mg/mL, injectable solution, Rx only, compounded by Moses Lake Pharmacy. | t03242015@21 and t06112015@37 | Class II | The firm is recalling Buprenorphine, injectable solution, due to lack of sterility assurance | JD & SN Inc., dba Moses Lake Professional Pharmacy |
Veterinary | Misoprostol (F.O.B.) 2 mg/5 mL oral Suspension NDC: 22200899801; Misoprostol (F.O.B) 1.4 mg/10 mL Suspension NDC: 22200894701. | 03182015@32, 03312015@36, 04162015@5, 05082015@3, 07072015@67, 03262015@38 | Class II | Firm determined that formulation was developed with the intent of using an active pharmaceutical ingredient with a potency of greater than or equal 99%. However, the active pharmaceutical ingredient used in the formulation acquired from the supplier was a 1% diluted product rendering the finished product as sub-potent. | US Compounding Inc |
Veterinary | Misoprostol 30 mL 1.4 mg/10 mL Paste NDC: 22200894630; Misoprostol 30 mL 1.4 mg/mL Paste NDC: 22200880730; Misoprostol 60 mL 1.4 mg/10 mL Paste NDC: 22200893660; Misoprostol 60 mL 1.6 mg/30 mL Paste NDC: 22200579460; Misoprostol 60 mL 1.6 mg/5 mL Paste NDC: 22200617260 | 03042015@1, 03232015@11, 03262015@1, 06102015@64, 01062015@30, 01082015@41, 02202015@44, 04242015@52, 02262015@1, 04022015@33, 04072015@3, 06092015@30, 06102015@4, 07062015@1, 07132015@65, 01222015@23, 01222015@25, 01282015@12, 02182015@39, 03232015@23 | Class II | Firm determined that formulation was developed with the intent of using an active pharmaceutical ingredient with a potency of greater than or equal 99%. However, the active pharmaceutical ingredient used in the formulation acquired from the supplier was a 1% diluted product rendering the finished product as sub-potent. | US Compounding Inc |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, November 19, 2015
Compounded Veterinary Drugs on FDA November 18, 2015 Enforcement Report
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment